MX2009008313A - Tratamiento de trastornos de consumo con bioestimulación. - Google Patents

Tratamiento de trastornos de consumo con bioestimulación.

Info

Publication number
MX2009008313A
MX2009008313A MX2009008313A MX2009008313A MX2009008313A MX 2009008313 A MX2009008313 A MX 2009008313A MX 2009008313 A MX2009008313 A MX 2009008313A MX 2009008313 A MX2009008313 A MX 2009008313A MX 2009008313 A MX2009008313 A MX 2009008313A
Authority
MX
Mexico
Prior art keywords
biostimulation
treatment
consumption disorders
consumption
disorders
Prior art date
Application number
MX2009008313A
Other languages
English (en)
Inventor
Mark Humayun
Sean Caffey
Jeff Brennan
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of MX2009008313A publication Critical patent/MX2009008313A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0548—Oral electrodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nervios que llevan las sensaciones de sabor al cerebro se estimulan para disminuir (o, dependiendo de la aplicación, aumentar) el placer asociado comúnmente con el comportamiento de consumo que se va a modificar.
MX2009008313A 2007-02-05 2008-02-04 Tratamiento de trastornos de consumo con bioestimulación. MX2009008313A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88812407P 2007-02-05 2007-02-05
US91772507P 2007-05-14 2007-05-14
US98203907P 2007-10-23 2007-10-23
PCT/US2008/001460 WO2008097515A1 (en) 2007-02-05 2008-02-04 Treatment of consumption disorders with biostimulation

Publications (1)

Publication Number Publication Date
MX2009008313A true MX2009008313A (es) 2010-02-18

Family

ID=41077789

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008313A MX2009008313A (es) 2007-02-05 2008-02-04 Tratamiento de trastornos de consumo con bioestimulación.

Country Status (7)

Country Link
EP (1) EP2114522B1 (es)
JP (1) JP2010517675A (es)
AU (1) AU2008214349B2 (es)
CA (1) CA2677364A1 (es)
ES (1) ES2399725T3 (es)
MX (1) MX2009008313A (es)
WO (1) WO2008097515A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8380315B2 (en) * 2009-10-05 2013-02-19 The Regents Of The University Of California Devices, systems and methods for treatment of neuropsychiatric disorders
US8983615B2 (en) * 2011-02-21 2015-03-17 Boston Scientific Neuromodulation Corporation System for communication with implantable medical devices using a bridge device
ES2550134B1 (es) * 2014-04-04 2016-08-19 Alberto ADARVE LOZANO Sistema simulador de sabores distintos de liquidos
JP6915848B2 (ja) * 2016-09-12 2021-08-04 国立大学法人大阪大学 味覚電気刺激装置
JP2023028676A (ja) 2021-08-20 2023-03-03 キリンホールディングス株式会社 味覚提示装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5062385A (en) * 1984-10-23 1986-05-15 Zion Foundation Method and apparatus for delivering a prescriptive electricalsignal
WO2003090599A2 (en) * 2002-04-25 2003-11-06 Brainsgate Ltd. Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
US6853858B2 (en) * 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US6609025B2 (en) * 2001-01-02 2003-08-19 Cyberonics, Inc. Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation
AU2004216247B8 (en) * 2003-02-25 2010-05-13 Advanced Neuromodulation Systems, Inc. D/B/A St. Jude Medical Neuromodulation Division Splanchnic nerve stimulation for treatment of obesity
WO2006008741A1 (en) * 2004-07-23 2006-01-26 Ben Zion Beiski Manufacturing methods, testing methods and testers for intra-oral electronically embedded devices

Also Published As

Publication number Publication date
CA2677364A1 (en) 2008-08-14
AU2008214349B2 (en) 2012-06-07
ES2399725T3 (es) 2013-04-03
WO2008097515A1 (en) 2008-08-14
EP2114522A1 (en) 2009-11-11
AU2008214349A1 (en) 2008-08-14
EP2114522B1 (en) 2012-11-21
JP2010517675A (ja) 2010-05-27

Similar Documents

Publication Publication Date Title
NL301145I1 (es)
MX2017002271A (es) Composiciones y metodos para el tratamiento de trastornos neurologicos.
TW200716140A (en) Treatment of inflammatory conditions
WO2014120619A3 (en) Compositions and methods of use in treating metabolic disorders
WO2008137633A3 (en) Methods of modulating cellular homeostatic pathways and cellular survival
WO2010028152A3 (en) Systems, devices and methods for the treatment of tinnitus
MY184241A (en) Human antibodies to gfr?3 and methods of use thereof
EP1786515A4 (en) TREATMENT OF THE VEGETABLE NERVOUS SYSTEM
MX2018008440A (es) Vectores de terapia genica y citosina deaminasas.
TW200740804A (en) Glucokinase activators
AU2008232453A8 (en) Methods and compositions for reduction of side effects of therapeutic treatments
WO2011038210A3 (en) Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
MX2011011958A (es) Metodos para el tratamiento de trastornos metabolicos utilizando cambiadores epimetabólicos, moléculas intracelulares multidimensionales o influenciadores ambientales.
MX2009011025A (es) Compuestos con actividad anticancer.
HK1145070A1 (en) Therapeutic use of a growth factor, metrnl
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
WO2008015383A3 (en) Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies
WO2008086483A3 (en) Modulation of neurogenesis with use of modafinil
HUE050758T2 (hu) Glutamátmoduláló szerek mentális rendellenességek kezelésére
MX2015017253A (es) Composiciones y metodos para tratar trastornos metabolicos.
WO2007122382A3 (en) Lycopene for the treatment of metabolic dysfunction
EP2633052A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH THE INTERFERON 1-RELATED DEVELOPMENT REGULATOR (IFRD1) BY INHIBITING THE NATURAL ANTISENSE TRANSCRIPTION PRODUCT OF IFRD1
AU2014212471A8 (en) Cystathionine beta-synthase enzyme for treatment of homocystinuria
MX2009008313A (es) Tratamiento de trastornos de consumo con bioestimulación.
WO2015009591A3 (en) Treatment for melanoma

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration